Chargement en cours...
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia, increases the morbidity and mortality of cardiovascular disease, type 2 diabetes, nonalcoholic fatty liver disease, and other metabolic diseases. It is well known that insulin resistance, especially hepatic insul...
Enregistré dans:
| Publié dans: | Front Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6795753/ https://ncbi.nlm.nih.gov/pubmed/31649547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01193 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|